Maciej Superson

Maciej Superson

Auto-generated profile, based on publicly available information

Maciej Superson

University Clinical Hospital Fryderyk Chopin, Szopena 2, 35-055 Rzeszów, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KWKamil Walczak
Kamil Walczak
JKJulia Krasnoborska
Julia Krasnoborska
SSSylwia Samojedny
Sylwia Samojedny
MSMaciej Superson
Maciej Superson
KSKatarzyna Szmyt
Katarzyna Szmyt
KWKlaudia Wilk-Trytko
Klaudia Wilk-Trytko
Background: Creatine, a naturally occurring compound plays a crucial role in cellular energy metabolism, particularly in tissues with high energy demands like muscles and the brain. Beyond its well-established role in physical performance enhancement, recent research has revealed its potential benefits for cognitive functions and mood regulation. This review paper aims to comprehensively analyze the existing literature on creatine supplementation's effects on cognitive functions and mood. State of Knowledge: Findings suggest that creatine supplementation enhances memory, attention, and executive functions, especially under conditions of stress or sleep deprivation. Moreover, it exhibits mood-stabilizing effects, potentially offering relief for symptoms of depression and fatigue. Creatine's ability to augment brain energy metabolism, alongside its neuroprotective properties, underlies its cognitive and mood-enhancing effects. While generally safe, caution is advised, particularly in populations with kidney diseases or those using medications affecting kidney function. Summary: Creatine emerges as a promising adjunct therapy for enhancing cognitive functions and promoting emotional well-being beyond its traditional role in physical performance.The review underscores the need for further research to elucidate the precise mechanisms of creatine's effects and explore its synergistic potential with other cognitive-enhancing supplements.

18 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MSMaciej Superson
Maciej Superson
KSKatarzyna Szmyt
Katarzyna Szmyt
KWKlaudia Wilk-Trytko
Klaudia Wilk-Trytko
JKJulia Krasnoborska
Julia Krasnoborska
SSSylwia Samojedny
Sylwia Samojedny
KWKamil Walczak
Kamil Walczak
Introduction and Purpose: In last years gene modification technologies such as CRISPR/Cas9 has had a revolutionary impact on the treatment of inherited diseases. Technologies developed from bacterial defense mechanisms, has become a basic tools in scientific research and medical therapies. In our article we provided an overview of applications of gene modifications technologies, directly focusing on CRISPR/Cas9, in genetic disease treatment. State of Knowledge: New applications of CRISPR/Cas9 are still being explored. Treating inherited diseases such as cystic fibrosis, Duchenne muscular dystrophy, thalassemia, hemophilia, Huntington's disease, Crigler-Najjar syndrome, sickle cell anemia, Marfan syndrome, and phenylketonuria, is feasible with this novel technique. A comparative analysis with other gene editing methods highlights CRISPR/Cas9's efficacy, ease of use, and multiplexing capabilities. Summary: CRISPR/Cas9 is a groundbreaking technology with broad applications in genetic research and therapy. Its ease of use, cost-effectiveness, and ability to target multiple genes simultaneously position it as a preferred method. However, there are some challenges associated with precision issues and ethical considerations in human embryo gene editing. As CRISPR/Cas9 continues to evolve, responsible application and ethical considerations are important for maximizing its potential in treatment of genetic diseases.

28 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KSKatarzyna Szymańska
Katarzyna Szymańska
KSKatarzyna Szmyt
Katarzyna Szmyt
JKJulia Krasnoborska
Julia Krasnoborska
SSSylwia Samojedny
Sylwia Samojedny
MSMaciej Superson
Maciej Superson
TDTomasz Andrzej Duplaga
Tomasz Andrzej Duplaga
Introduction: Artificial Intelligence (AI) has emerged as a seminal force in healthcare, fundamentally transforming various aspects of medical practice and patient care. This review explores the transformative impact of AI on the treatment of cardiovascular diseases (CVDs). State of Knowledge: AI has revolutionized diagnostic accuracy, treatment precision, and patient management in the realm of cardiovascular care. It enhances diagnostic processes, enabling the early detection of CVDs through advanced imaging analysis and interpretation. Additionally, AI facilitates precision in risk stratification, identifying high-risk patient cohorts with heightened accuracy and informing personalized treatment strategies. Furthermore, AI optimizes drug selection and dosage regimens through pharmacogenomics, maximizing therapeutic efficacy while minimizing adverse drug reactions. Moreover, AI improves precision and safety during interventional procedures, guiding clinicians in real-time decision-making and enhancing procedural outcomes. Conclusions: AI is poised to revolutionize cardiovascular care, fostering innovation and improving patient outcomes.

22 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JZJulia Zarębska
Julia Zarębska
JKJulia Krasnoborska
Julia Krasnoborska
SSSylwia Samojedny
Sylwia Samojedny
MSMaciej Superson
Maciej Superson
KSKatarzyna Szmyt
Katarzyna Szmyt
ŁZŁukasz Piotr Zarębski
Łukasz Piotr Zarębski
Background: The symbiotic relationship between the gut microbiota and cardiovascular health has become a main point in contemporary research, offering valuable insights into the pathogenesis of cardiovascular diseases (CVDs). This review aims to comprehensively examine the bidirectional communication between gut microbial communities and the cardiovascular system, explaining the intricate mechanisms that connect gut dysbiosis to the initiation and progression of CVDs. Material and Methods: A systematic literature review was conducted to compile and analyze relevant studies investigating the impact of the gut microbiota on cardiovascular health. Emphasis was placed on explaining the molecular and physiological mechanisms underlying the interaction between gut microbes and cardiovascular function. Results: Our review confirmed evidence linking gut microbiota-derived metabolites, such as short-chain fatty acids, trimethylamine N-oxide and lipopolysaccharides to vascular function and inflammation. Additionally, we explored the modulation of host metabolism and immune responses by gut microbes, providing insights into their roles in atherosclerosis and hypertension. The review highlight the influence of diet and lifestyle on shaping the gut microbiome and, consequently, cardiovascular outcomes. Conclusions: Gut microbiota plays a crucial role in cardiovascular health and is involved in the start and development of various heart diseases. The identified molecular and physiological mechanisms highlight the need for complete understanding of the gut-cardiovascular axis. Moreover, the review emphasizes the potential of microbiota-targeted interventions, including probiotics and fecal microbiota transplantation, as innovative strategies for preventing and managing CVDs.

24 March 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KSKatarzyna Szymańska
Katarzyna Szymańska
JKJulia Krasnoborska
Julia Krasnoborska
SSSylwia Samojedny
Sylwia Samojedny
MSMaciej Superson
Maciej Superson
KSKatarzyna Szmyt
Katarzyna Szmyt
ŁZŁukasz Piotr Zarębski
Łukasz Piotr Zarębski
Introduction and purpose: Gaucher's Disease (GD), a rare genetic disorder, is a difficult challenge in genetic and metabolic disorders. The aim of this review is to provide an exploration of GD, spanning its pathophysiology to the latest advancements in diagnostic and therapeutic innovations. In this review we aimed to underscore the challenges it presents and the ongoing efforts to overcome them. State of knowledge: GD, characterized by the accumulation of glucocerebroside, involves molecular, cellular, and systemic dysfunctions. At the molecular level, mutations in the GBA gene give rise to diverse manifestations, influencing disease severity. Cellular disruptions lead to lysosomal dysfunction, altered calcium homeostasis, and chronic inflammation, impacting various organ systems. Diagnostic approaches involve biomarkers, genetic testing, and imaging studies, each playing a crucial role in confirming the disease type and assessing its grade. Summary: Management and treatment strategies for GD have evolved, with enzyme replacement therapy and substrate reduction therapy serving as the basics. However, challenges persist, including limited efficacy in treating neurological symptoms and the high cost of treatments. The review highlights ongoing research and future perspectives in GD therapy.

6 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JKJulia Krasnoborska
Julia Krasnoborska
KSKatarzyna Szmyt
Katarzyna Szmyt
SSSylwia Samojedny
Sylwia Samojedny
KSKatarzyna Szymańska
Katarzyna Szymańska
KWKamil Walczak
Kamil Walczak
JZJuia Zarębska
Juia Zarębska
Introduction and purpose: Chronic inflammation in the oral cavity poses significant risks to both the heart and the circulatory system. A growing number of studies indicate a correlation between periodontal health and the likelihood of developing cardiovascular conditions, including myocardial infarction, coronary artery disease, hypertension, and stroke. This review aims to summarize recent reports, define current state of knowledge, and propose optimal treatment and prevention strategies. State of knowledge: Risk factors such as obesity, smoking, and genetic predisposition contribute to the development of both PD and cardiovascular diseases (CVDs). Inflammation serves as a common factor linking the two conditions, with periodontal pathogens directly affecting cardiovascular health. Epigenetic mechanisms, particularly in response to environmental stimuli, further exacerbate the relationship between PD and CVDs. Additionally, the oral microbiome plays a crucial role, with periodontal pathogens infiltrating systemic circulation and triggering immune-inflammatory responses that promote cardiovascular damage. Conclusions: People with periodontitis have a higher risk of CVDs, especially when other risk factors such as smoking and obesity are present. Periodontal treatment has been demonstrated to enhance cardiovascular health parameters. Implementing preventive strategy, addressing both periodontitis and cardiovascular risk factors, could potentially decrease morbidity and mortality associated with cardiovascular disease.